1. Home
  2. FULC vs NC Comparison

FULC vs NC Comparison

Compare FULC & NC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • NC
  • Stock Information
  • Founded
  • FULC 2015
  • NC 1913
  • Country
  • FULC United States
  • NC United States
  • Employees
  • FULC N/A
  • NC N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • NC Coal Mining
  • Sector
  • FULC Health Care
  • NC Energy
  • Exchange
  • FULC Nasdaq
  • NC Nasdaq
  • Market Cap
  • FULC 210.9M
  • NC 247.6M
  • IPO Year
  • FULC 2019
  • NC N/A
  • Fundamental
  • Price
  • FULC $2.90
  • NC $32.56
  • Analyst Decision
  • FULC Hold
  • NC
  • Analyst Count
  • FULC 8
  • NC 0
  • Target Price
  • FULC $6.57
  • NC N/A
  • AVG Volume (30 Days)
  • FULC 427.3K
  • NC 10.0K
  • Earning Date
  • FULC 02-25-2025
  • NC 03-05-2025
  • Dividend Yield
  • FULC N/A
  • NC 2.76%
  • EPS Growth
  • FULC N/A
  • NC N/A
  • EPS
  • FULC N/A
  • NC 4.55
  • Revenue
  • FULC $80,000,000.00
  • NC $237,708,000.00
  • Revenue This Year
  • FULC N/A
  • NC N/A
  • Revenue Next Year
  • FULC N/A
  • NC N/A
  • P/E Ratio
  • FULC N/A
  • NC $7.20
  • Revenue Growth
  • FULC 2752.05
  • NC 10.67
  • 52 Week Low
  • FULC $2.78
  • NC $25.19
  • 52 Week High
  • FULC $11.85
  • NC $34.74
  • Technical
  • Relative Strength Index (RSI)
  • FULC 29.80
  • NC 52.85
  • Support Level
  • FULC $2.82
  • NC $32.26
  • Resistance Level
  • FULC $3.09
  • NC $33.97
  • Average True Range (ATR)
  • FULC 0.30
  • NC 1.33
  • MACD
  • FULC -0.04
  • NC -0.02
  • Stochastic Oscillator
  • FULC 10.86
  • NC 44.40

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.

Share on Social Networks: